Diabetes can be managed and controlled with various injectable treatments available on the market: Insulin, GLP-1, and glucagon.
Diabetes is a severe and chronic disease that has been steadily increasing over the past few decades.
Globally, an estimated 422 million adults were living with diabetes in 2014, compared to 108 million in 1980; This reflects an increase in associated risk factors such as being overweight or obese. Recently, diabetes prevalence has risen faster in low- and middle-income countries than in higher-income countries*.
Treatments require high reliability in supply for high volumes, avoiding line stops, and reducing false rejects. Moreover, for containers like cartridges, integrating with drug delivery systems such as pen injectors, auto-injectors, and wearable is essential. For this reason, the container closure system/device compatibility must be thoroughly assessed to provide end-users and patients reliable and effective administration means.
*Source: 2016 Global Report on Diabetes, World Health Organization
Drug containment solutions
For decades, Stevanato Group has been working to provide the best drug containment solutions to pharmaceutical companies leading in the insulin market: Today Stevanato Group is the first world’s largest manufacturer of glass cartridge systems for insulin dedicated to the treatment of diabetes.
Services
We provide comprehensive container closure characterization of the primary packaging to find the most suitable solutions for each drug formulation.
Drug delivery systems
We can support your drug delivery device projects dedicated to the diabetes care through our proprietary offer and contract manufacturing capabilities
Visual Inspection
Stevanato Group’s leadership in the anti-diabetic field is not limited only to glass containers, but also to automatic visual inspection. With a patented 5-step method, including the use of line scan cameras, we offer robust inspection processes for insulin.
Diagnostic components
We produce customized diagnostic and laboratory consumables, point of care consumables, and handheld devices with integrated diagnostic functionality.
Assembly lines
With a 30-year expertise in assembling devices for diabetes treatment, Stevanato Group offers a full range of flexible and scalable solutions to streamline the sub-assembly and final assembly of auto-injectors and pen injectors.
Free Live Webinar series: Advanced and Integrated Solutions for Biopharmas and Diagnostics.
Other markets we serve
Novel glass primary packaging and drug delivery devices suitable for the new generation of drugs combined with state-of-art analytical services and reliable technologies.
We offer different solutions linked to sublingual and nasal drug administration. Effective, safe, and simple drug delivery guide our R&D in this field.
We have become a key partner for pharmaceutical companies specializing in anticoagulants providing glass syringes, safety systems, and state of the art technologies such as automatic vision inspection and high yield handling systems
Prefillable syringes and vials suitable for high-speed, high-volume production. Reliable particle inspection, as well as complementary technologies, such as leak detection to test container integrity.
Novel glass primary packaging and drug delivery devices suitable for the new generation of drugs combined with state-of-art analytical services and reliable technologies.
We offer different solutions linked to sublingual and nasal drug administration. Effective, safe, and simple drug delivery guide our R&D in this field.
We have become a key partner for pharmaceutical companies specializing in anticoagulants providing glass syringes, safety systems, and state of the art technologies such as automatic vision inspection and high yield handling systems
Prefillable syringes and vials suitable for high-speed, high-volume production. Reliable particle inspection, as well as complementary technologies, such as leak detection to test container integrity.